CD44 and neoplasm: The copper-based nanomedicine (PCB), containing an internal BPTES and copper nanoparticles (Cu-NPs) core as well as an external platelet membrane (PM), contributed to the specific recognition of CD44 proteins highly expressed in tumor cells after intravesical administration thereby targeting the tumor site.